Arama Sonuçları - Shingo Nakayamada

Sonuçları Daraltın
  1. 1
    BAFF- and APRIL-targeted therapy in systemic autoimmune diseases

    BAFF- and APRIL-targeted therapy in systemic autoimmune diseases Yazar: Shingo Nakayamada, Yoshiya Tanaka

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Use of mesenchymal stem cells seeded on the scaffold in articular cartilage repair

    Use of mesenchymal stem cells seeded on the scaffold in articular cartilage repair Yazar: Kaoru Yamagata, Shingo Nakayamada, Yoshiya Tanaka

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry

    Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry Yazar: Sae Ochi, Koshiro Sonomoto, Shingo Nakayamada, Yoshiya Tanaka

    Baskı/Yayın Bilgisi 2022
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Helper T cell diversity and plasticity

    Helper T cell diversity and plasticity Yazar: Shingo Nakayamada, Hayato Takahashi, Yuka Kanno, John J. O’Shea

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  5. 5
    Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach

    Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach Yazar: Yoshiya Tanaka, Yiming Luo, John J. O’Shea, Shingo Nakayamada

    Baskı/Yayın Bilgisi 2022
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  6. 6
    Rituximab in the real-world treatment of lupus nephritis: A retrospective cohort study in Japan

    Rituximab in the real-world treatment of lupus nephritis: A retrospective cohort study in Japan Yazar: Yoshiya Tanaka, Shingo Nakayamada, Kunihiro Yamaoka, Koichiro Ohmura, Shinsuke Yasuda

    Baskı/Yayın Bilgisi 2022
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  7. 7
    Real-World Safety and Efficacy of Targeted Therapies in Rheumatoid Arthritis: A 5-Year, 5130-Case Follow-Up from FIRST Registry

    Real-World Safety and Efficacy of Targeted Therapies in Rheumatoid Arthritis: A 5-Year, 5130-Case Follow-Up from FIRST Registry Yazar: Koshiro Sonomoto, Shingo Nakayamada, Hiroaki Tanaka, Atsushi Nagayasu, Yoshiya Tanaka

    Baskı/Yayın Bilgisi 2025
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  8. 8
    Induction of Regulatory T Cells and Its Regulation with Insulin-like Growth Factor/Insulin-like Growth Factor Binding Protein-4 by Human Mesenchymal Stem Cells

    Induction of Regulatory T Cells and Its Regulation with Insulin-like Growth Factor/Insulin-like Growth Factor Binding Protein-4 by Human Mesenchymal Stem Cells Yazar: Ippei Miyagawa, Shingo Nakayamada, Kazuhisa Nakano, Kaoru Yamagata, Kei Sakata, Kunihiro Yamaoka, Yoshiya Tanaka

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  9. 9
    Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus

    Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus Yazar: Kei Sakata, Shingo Nakayamada, Yusuke Miyazaki, Satoshi Kubo, Akina Ishii, Kazuhisa Nakano, Yoshiya Tanaka

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  10. 10
    Efficacy and safety of tofacitinib versus baricitinib in patients with rheumatoid arthritis in real clinical practice: analyses with propensity score-based inverse probability of treatment weighting

    Efficacy and safety of tofacitinib versus baricitinib in patients with rheumatoid arthritis in real clinical practice: analyses with propensity score-based inverse probability of t... Yazar: Yusuke Miyazaki, Kazuhisa Nakano, Shingo Nakayamada, Satoshi Kubo, Yoshino Inoue, Yoshihisa Fujino, Yoshiya Tanaka

    Baskı/Yayın Bilgisi 2021
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  11. 11
    Spatial congregation of STAT binding directs selective nuclear architecture during T-cell functional differentiation

    Spatial congregation of STAT binding directs selective nuclear architecture during T-cell functional differentiation Yazar: Ofir Hakim, Myong‐Hee Sung, Shingo Nakayamada, Ty C. Voss, Songjoon Baek, Gordon L. Hager

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  12. 12
    Efficacy and Safety of Rituximab in Connective Tissue Disease‐Associated Thrombotic Thrombocytopenic Purpura/Thrombotic Microangiopathy

    Efficacy and Safety of Rituximab in Connective Tissue Disease‐Associated Thrombotic Thrombocytopenic Purpura/Thrombotic Microangiopathy Yazar: Naoaki Ohkubo, Shingo Nakayamada, Shunsuke Fukuyo, Yusuke Miyazaki, Yoshino Inoue, Hiroaki Tanaka, Yasuyuki Todoroki, Yoshiya Tanaka

    Baskı/Yayın Bilgisi 2025
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  13. 13
    STATs Shape the Active Enhancer Landscape of T Cell Populations

    STATs Shape the Active Enhancer Landscape of T Cell Populations Yazar: Golnaz Vahedi, Hayato Takahashi, Shingo Nakayamada, Hong‐Wei Sun, Vittorio Sartorelli, Yuka Kanno, John J. O’Shea

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  14. 14
    Precision medicine using different biological DMARDs based on characteristic phenotypes of peripheral T helper cells in psoriatic arthritis

    Precision medicine using different biological DMARDs based on characteristic phenotypes of peripheral T helper cells in psoriatic arthritis Yazar: Ippei Miyagawa, Shingo Nakayamada, Kazuhisa Nakano, Satoshi Kubo, S. Iwata, Yusuke Miyazaki, Maiko Yoshikawa, Hiroko Yoshinari, Yoshiya Tanaka

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  15. 15
    Janus kinases to jakinibs: from basic insights to clinical practice

    Janus kinases to jakinibs: from basic insights to clinical practice Yazar: Massimo Gadina, Mimi T. Le, Daniella M. Schwartz, Olli Silvennoinen, Shingo Nakayamada, Kunihiro Yamaoka, John J. O’Shea

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  16. 16
    Helper T-cell differentiation and plasticity: insights from epigenetics

    Helper T-cell differentiation and plasticity: insights from epigenetics Yazar: Kiyoshi Hirahara, Golnaz Vahedi, Kamran Ghoreschi, Xiang‐Ping Yang, Shingo Nakayamada, Yuka Kanno, John J. O’Shea, Arian Laurence

    Baskı/Yayın Bilgisi 2011
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  17. 17
    Tacrolimus, a Calcineurin Inhibitor, Overcomes Treatment Unresponsiveness Mediated by P-glycoprotein on Lymphocytes in Refractory Rheumatoid Arthritis

    Tacrolimus, a Calcineurin Inhibitor, Overcomes Treatment Unresponsiveness Mediated by P-glycoprotein on Lymphocytes in Refractory Rheumatoid Arthritis Yazar: Katsunori Suzuki, Kazuyoshi Saito, Shizuyo Tsujimura, Shingo Nakayamada, Kunihiro Yamaoka, Norifumi Sawamukai, S. Iwata, Masao Nawata, Kazuhisa Nakano, Yoshiya Tanaka

    Baskı/Yayın Bilgisi 2010
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  18. 18
    Th22 Cells Promote Osteoclast Differentiation via Production of IL-22 in Rheumatoid Arthritis

    Th22 Cells Promote Osteoclast Differentiation via Production of IL-22 in Rheumatoid Arthritis Yazar: Yusuke Miyazaki, Shingo Nakayamada, Satoshi Kubo, Kazuhisa Nakano, S. Iwata, Ippei Miyagawa, Xiaoxue Ma, Gulzhan Trimova, Kei Sakata, Yoshiya Tanaka

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  19. 19
    Correlation of T follicular helper cells and plasmablasts with the development of organ involvement in patients with IgG4-related disease

    Correlation of T follicular helper cells and plasmablasts with the development of organ involvement in patients with IgG4-related disease Yazar: Satoshi Kubo, Shingo Nakayamada, Jidong Zhao, Maiko Yoshikawa, Yusuke Miyazaki, Aya Nawata, Shintaro Hirata, Kazuhisa Nakano, Kazuyoshi Saito, Yoshiya Tanaka

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  20. 20
    Janus Kinase Inhibitor Baricitinib Modulates Human Innate and Adaptive Immune System

    Janus Kinase Inhibitor Baricitinib Modulates Human Innate and Adaptive Immune System Yazar: Satoshi Kubo, Shingo Nakayamada, Kei Sakata, Yukihiro Kitanaga, Xiaoxue Ma, Seunghyun Lee, Akina Ishii, Kaoru Yamagata, Kazuhisa Nakano, Yoshiya Tanaka

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: